Full-Time

Microbiologist 3

Quality Control

Deadline 11/16/26
Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

No salary listed

Albuquerque, NM, USA

In Person

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Microsoft Office
ISO 9001
GMP
Word/Pages/Docs
Microbiology
Excel/Numbers/Sheets
Microsoft Outlook
PowerPoint/Keynote/Slides

Get referred to Curia

See people who can refer or advise you

Requirements
  • A bachelor's degree in a scientific discipline, preferably microbiology or a related field.
  • A minimum of five years of related work experience.
  • Knowledge of FDA current Good Manufacturing Practices, including 21 CFR 211.
  • The ability to read and interpret safety instructions, standard operating procedures, technical procedures, and governmental regulations.
  • Proficiency in arithmetic operations, algebraic and geometric principles, and interpreting technical instructions in mathematical or diagram form.
  • Proficiency with manufacturing and internet software and Microsoft Office tools, including PowerPoint, Excel, Word, and Outlook.
  • The ability to pass a background check and drug screen.
  • The ability to obtain and maintain gowning certification and media qualification.
  • The ability to wear a respirator.
  • The ability to perform the listed physical requirements, including lifting, pushing, pulling, sitting, standing, reaching, and hand and finger dexterity.
Responsibilities
  • Perform microbiological testing for endotoxin, sterility, bioburden, microbial limits, and enumeration across raw materials, in-process materials, intermediates, final products, and utilities.
  • Perform environmental monitoring of cleanrooms in compliance with United States Pharmacopeia and European Union specifications.
  • Review, trend, and report environmental, personnel, in-process, raw material, finished product, and utilities testing results.
  • Conduct microbial characterization using gram stain, catalase, oxidase, and coagulase tests, and prepare and send samples for microbiological identification.
  • Maintain historical files for organisms found in classified areas, including microbial identification and trending.
  • Perform line clearances and line-start verifications and inspect media fills.
  • Serve as the subject matter expert for sterility assays, including biological indicator testing, and growth-promotion testing for incoming laboratory media.
  • Process quality-control microbiological samples, including receipt, logging, testing, tracking, distribution of results, and closure.
  • Author and revise controlled documents, including standard operating procedures, investigational protocols, and risk assessments.
  • Initiate out-of-specification and environmental-monitoring-excursion investigations, recommend corrective and preventive actions, and complete effectiveness checks.
  • Oversee equipment cleaning and maintenance, supplies, inventory, vendor maintenance, preventive maintenance, and equipment calibration.
  • Maintain laboratory housekeeping and a clean, organized workspace.
  • Facilitate the revision and release of controlled documents.
  • Coordinate mandatory standard operating procedure reviews and month-end reports.
  • Read and interpret standard operating procedures to ensure compliance.
  • Maintain current training.
  • Provide guidance and mentorship to team members.
  • Promote a safe and healthy work environment by identifying hazards, following safety protocols, participating in safety training, and fostering safety awareness.
  • Provide project oversight for updating and maintaining official document templates and direct and manage the change-control system.
  • Use spreadsheets for data entry, basic calculations, and organization of microbiological data.
Desired Qualifications
  • At least three years of industry experience in a Good Manufacturing Practice or Good Laboratory Practice environment.
  • Previous experience with pharmaceutical cleanroom environments.
  • Knowledge of ISO 9001, ISO 13485, and ISO 17025.
  • Experience and proficiency in validation and qualification of laboratory microbiological techniques.

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Albuquerque’s $200 million expansion adds commercial drug-product capacity during 2025-2026.
  • Glasgow’s upgrade reaches early 2027, expanding batches to 20,000 vials.
  • March 2025 refinancing and July 2026 recapitalization inject capital for near-term execution.

What critics are saying

  • Apollo-led recapitalization on July 8, 2026 signals strained leverage and lender control.
  • Curia will close Burlington by June 1, 2026, cutting 81 jobs and shrinking capacity.
  • Octus reported June 2, 2026 out-of-court restructuring talks; a failed process risks insolvency.

What makes Curia unique

  • Curia spans discovery through commercial fill-finish across 20+ sites, rare among CDMOs.
  • Glasgow and Albuquerque expansions deepen sterile injectables capacity, including Annex 1 isolator lines.
  • Hopkinton CLD upgrades deliver sixfold higher titers, strengthening biologics process-development economics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.